Nospharma's pipeline includes novel small-molecule and peptide therapeutics for rare genetic neurological disorders with major unmet need.
By placing biology-first, we've created novel treatments and repurposed on-the-market therapies to improve treatment success.
Partnerships
Contact us to learn more about co-development and licensing opportunities of our pipeline. By partnering with us, together we can develop first-line therapeutics for the treatment rare neurological disorders.